While CARs containing the CD28 domain generate a faster, stronger signal than those containing the 4-1BB domain, leading to a more potent target cell killing activity, CD28-CARs also demonstrated limited long-term survival and anti-tumor durability due to CAR-T cell exhaustion [41, 42]. This evidence concerns the gene CD28 and neoplasm.